drugset / Trial / NCT01025271
Cerebrospinal Fluid Pharmacokinetics of Daptomycin
Terminated
2 enrolled
University of Pittsburgh
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) · collab
NaSingle-groupOpen-labelDiagnostic
Summary
This is a prospective pharmacokinetic study in patients having external ventricular drains with suspected external ventricular drain related bacterial meningitis. A single dose of daptomycin will be administered for the purposes of the study and PK samples will be obtained around this dosing.
Timeline
- Start
- 2010-05
- Primary completion
- 2011-05
- Completion
- 2011-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Daptomycin | Other / unclassified | 10 mg/kg | Intravenous |